Leerink Partnrs Has Negative Estimate for A Q1 Earnings

Agilent Technologies, Inc. (NYSE:A) – Leerink Partnrs lowered their Q1 2025 earnings estimates for Agilent Technologies in a note issued to investors on Tuesday, November 26th. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will earn $1.28 per share for the quarter, down from their prior estimate of $1.36. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.24 per share. Leerink Partnrs also issued estimates for Agilent Technologies’ Q2 2025 earnings at $1.33 EPS, Q3 2025 earnings at $1.41 EPS, Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.57 EPS and FY2026 earnings at $6.10 EPS.

Other research analysts also recently issued research reports about the stock. Sanford C. Bernstein cut their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday. Barclays increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday. Evercore ISI raised their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company started coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price objective on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $144.07.

Agilent Technologies Price Performance

Shares of A stock opened at $134.35 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The stock has a fifty day simple moving average of $137.74 and a two-hundred day simple moving average of $137.43. The stock has a market capitalization of $38.60 billion, a price-to-earnings ratio of 27.87, a P/E/G ratio of 5.89 and a beta of 1.07. Agilent Technologies has a twelve month low of $124.10 and a twelve month high of $155.35.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 19.50%.

Insider Buying and Selling at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Hedge Funds Weigh In On Agilent Technologies

A number of hedge funds have recently made changes to their positions in A. Massachusetts Financial Services Co. MA boosted its position in Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after acquiring an additional 525,214 shares during the last quarter. State Street Corp increased its holdings in shares of Agilent Technologies by 1.2% in the third quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock valued at $1,903,498,000 after purchasing an additional 158,175 shares during the last quarter. Geode Capital Management LLC lifted its position in Agilent Technologies by 0.4% during the third quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock worth $1,028,241,000 after buying an additional 30,610 shares in the last quarter. Van ECK Associates Corp grew its holdings in Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after buying an additional 183,716 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Agilent Technologies by 4.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,948,536 shares of the medical research company’s stock worth $437,799,000 after acquiring an additional 136,184 shares during the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.